Friess Associates’s Nu Skin NUS Stock Holding History

Friess Associates’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-182,975	Closed	-$25.3M	–	163
2013 Q4	$25.3M	Buy	+182,975	New	+$21.5M	1.9%	18

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ESG

Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Friess Associates's NUS Position: Q1 2014 in Review

Friess Associates sold out of Nu Skin (NUS) in Q1 2014, closing a stake of 182,975 shares — an estimated $25.3M sold.

Friess Associates first reported a position in NUS in Q4 2013 and held it in 1 quarter. The position peaked at $25.3M in Q4 2013. 289 funds tracked by Wall St. Rank hold NUS as of Q1 2014.

Friess Associates reported no remaining Nu Skin position as of Q1 2014 after selling out during the quarter.
Friess Associates sold 182,975 Nu Skin shares in Q1 2014, an estimated $25.3M.
Friess Associates first reported a position in Nu Skin in Q4 2013 and held it in 1 quarter.
Friess Associates's Nu Skin position peaked at $25.3M in Q4 2013.
289 funds tracked by Wall St. Rank held Nu Skin as of Q1 2014.

Based on Friess Associates's 13F filing for Q1 2014, filed 15 May 2014.